ICH Pharma Quality Guideline
ICH Guideline Link
I. Q1A – Q1F STABILITY
Q1A (R2) Stability Testing of New Drug Substances and Products
Q1B Stability Testing: Photostability Testing of New Drug Substances and Products
Q1C Stability Testing for New Dosage Forms
Q1D Bracketing and Matrixing Designs for Stability Testing of New Drug Substances and Products
Q1E Evaluation of Stability Data
Q1F Stability Data Package for Registration Applications in Climatic Zones III and IV
Explanatory Note on the Withdrawal of ICH Q1F for the ICH Website
II. Q2 ANALYTICAL VALIDATION
III. Q3A – Q3D IMPURITIES
Q3A(R2)Impurities in New Drug Substances
Q3B(R2)Impurities in New Drug Products
Q3C(R5)Impurities: Guideline for Residual Solvents
Q3DGuideline for Elemental Impurities
IV. Q4 – Q4B Pharmacopoeias
Q4B ANNEX 5(R1) DISINTEGRATION TEST
Q4B ANNEX 6 UNIFORMITY OF DOSAGE UNITS
Q4B ANNEX 7(R2) DISSOLUTION TEST
Q4B ANNEX 8(R1) STERILITY TEST
Q4B ANNEX 9(R1) TABLET FRIABILITY
Q4B ANNEX 10(R1) POLYACRYLAMIDE GEL ELECTROPHORESIS
Q4B ANNEX 11 CAPILLARY ELECTROPHORESIS
Q4B ANNEX 12 ANALYTICAL SIEVING
Q4B ANNEX 13 BULK DENSITY AND TAPPED DENSITY OF POWDERS
Q4B ANNEX 14 BACTERIAL ENDOTOXINS TEST
Q5A – Q5E Quality of Biotechnological Products
VI. Q6A- Q6B Specifications
Q6B
VII. Q7 Good Manufacturing Practice
VIII. Q8 Pharmaceutical Development
IX. Q9 Quality Risk Management
Q8/9/10 Points to Consider (R2)
X. Q10 Pharmaceutical Quality System
XI. Q11 Development and Manufacture of Drug Substances
For More Pharma Updates Visit –https://pharmaguidances.com